drugset / Trial / NCT00703898

Durability of Nevirapine-Based Antiretroviral Regimen

NCT00703898

Phase 4 Completed 140 enrolled Bamrasnaradura Infectious Diseases Institute
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Although nevirapine is used as an alternative to efavirenz for initial regimen in developed countries, nevirapine has still been a key antiretroviral drug in many resource-limited countries including Thailand due to its accessibility and affordability. In addition, a component of stavudine and lamivudine is still widely used as a backbone in the antiretroviral regimen in this setting.To date, data on the durability of a regimen of stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited settings.

Timeline

Start
2004-11
Primary completion
2009-12
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule 200 mg